Deal date

KANDO id: 1046276

Financial Transaction:

Series C


Chromacode Inc



Note
Investment to support the launch of ChromaCode’s multi-drug resistant bacteria panel, tick-borne pathogen panel, SARS-CoV-2 panel, and upper-respiratory-tract infection panel.

Round participants

Country Notes

Adjuvant Capital

 Initial investment.

Domain Associates LLC

Venture capital firm focused on life sciences companies. 		United States Initial investment.

New Enterprise Associates Inc

(NEA)
Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. 		United States Initial investment.

Northpond Ventures

Science-driven venture capital firm headquartered in Bethesda, Maryland. 		United States Initial investment.